Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors [Phase 1]
Phase 1 clinical trial update indicates a study of Olaparib in combination with ASTX727 for BRCA1/2- and homologous recombination deficiency…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) [NA]
Completed clinical trial PREPARE evaluated a geriatric intervention in the treatment of older cancer patients. The update does not include t…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of CYH33 in patients with recurrent/persistent ovarian clear cell carcinoma.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery [NA]
Clinical trial update on the impact of targeted intraoperative analgesia monitoring under general anesthesia on chronic pain after ovarian c…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Phase I Trial of VS-6766 Alone and in Combination With Everolimus [Phase 1]
Completed Phase I trial evaluating VS-6766 alone and in combination with everolimus in patients with solid tumors, multiple myeloma, lung ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Performance Study of (Opportunistic) Salpingectomy [NA]
This document notes the completion of a clinical trial evaluating opportunistic salpingectomy as a surgical approach for patients with adnex…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of PHN-010 in Patients With Advanced Solid Tumors [Phase 1]
PHN-010 Phase 1 trial in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS other · 2026-01-29Clinical Trial Update: Diet, Hepcidin, and Chemotherapy RDI
George Washington University announces an active-not-recruiting clinical trial evaluating how diet and hepcidin affect chemotherapy dose int…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management [NA]
This ClinicalTrials.gov update describes a study evaluating pretreatment sarcopenia in patients with inoperable high-grade ovarian carcinoma…
-
EMA approval · 2026-01-28EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited
EMA authorised Abevmy (bevacizumab) as a biosimilar. It is approved for several cancer indications including colorectal, breast, ovarian, fa…
-
EMA approval · 2026-01-28EMA Authorised: Oyavas (bevacizumab) — STADA Arzneimittel AG
EMA authorised Oyavas, a bevacizumab biosimilar by STADA, for multiple indications including colorectal, breast, ovarian, fallopian tube, pe…
-
EMA approval · 2026-01-28EMA Authorised: Vegzelma (bevacizumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Vegzelma, a bevacizumab biosimilar from Celltrion Healthcare Hungary Kft., for multiple cancers including colorectal, breast,…
-
EMA approval · 2026-01-28EMA Authorised: Aybintio (bevacizumab) — Samsung Bioepis NL B.V.
The EMA authorised Aybintio, a bevacizumab biosimilar from Samsung Bioepis NL B.V., for multiple cancer indications including colorectal, br…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study [NA]
This is a pilot study evaluating an e-health Day-by-Day intervention to help manage Fear of Progression in women with stage III or IV gyneco…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating telmisartan in combination with cytotoxic chemotherapy for platinum-resistant ovarian cancer is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating IMP4297 in BRCA1/2 mutation-associated ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 3]
A Phase 3 clinical trial assessing IMP4297 as maintenance therapy after first-line chemotherapy in patients with advanced ovarian cancer; th…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Registry Platform Ovarian and Endometrial Cancer
This is a ClinicalTrials.gov registry entry for a recruiting study sponsored by iOMEDICO AG, investigating ovarian cancer and endometrial ca…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer [Phase 3]
This Phase 3 clinical trial update outlines CALM-TF, a trauma-focused psychotherapy program, being studied for newly diagnosed and recurrent…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]
Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pan…
-
EMA approval · 2026-01-27EMA Authorised: Mvasi (bevacizumab) — Amgen Technology (Ireland) UC
EMA authorised Mvasi (bevacizumab) from Amgen as a biosimilar to bevacizumab for multiple cancer indications including renal cell carcinoma,…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is planned to evaluate the efficacy and safety of JPI-547 in combination with bevacizumab as maintenance therapy fo…
-
EMA approval · 2026-01-27EMA Authorised: Avastin (bevacizumab) — Roche Registration GmbH
The EMA authorised Avastin (bevacizumab) under Roche Registration GmbH for multiple cancer indications. The listed diseases include non-smal…